These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 37187125)

  • 1. Diagnosis and monitoring of virus-associated cancer using cell-free DNA.
    Scholte LL; Bethony JM; Xian RR
    Curr Opin Virol; 2023 Jun; 60():101331. PubMed ID: 37187125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.
    Cervena K; Vodicka P; Vymetalkova V
    Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.
    Luo H; Wei W; Ye Z; Zheng J; Xu RH
    Trends Mol Med; 2021 May; 27(5):482-500. PubMed ID: 33500194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
    Zeng H; He B; Yi C; Peng J
    J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor DNA in liquid biopsy: Current diagnostic limitation.
    Liu SC
    World J Gastroenterol; 2024 Apr; 30(15):2175-2178. PubMed ID: 38681986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy and its role in an advanced clinical trial for lung cancer.
    Johann DJ; Steliga M; Shin IJ; Yoon D; Arnaoutakis K; Hutchins L; Liu M; Liem J; Walker K; Pereira A; Yang M; Jeffus SK; Peterson E; Xu J
    Exp Biol Med (Maywood); 2018 Feb; 243(3):262-271. PubMed ID: 29405770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics.
    Song P; Wu LR; Yan YH; Zhang JX; Chu T; Kwong LN; Patel AA; Zhang DY
    Nat Biomed Eng; 2022 Mar; 6(3):232-245. PubMed ID: 35102279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies.
    Jiang P; Chan KCA; Lo YMD
    J Hepatol; 2019 Aug; 71(2):409-421. PubMed ID: 31004682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy: paving a new avenue for cancer research.
    Kurma K; Eslami-S Z; Alix-Panabières C; Cayrefourcq L
    Cell Adh Migr; 2024 Dec; 18(1):1-26. PubMed ID: 39219215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Free DNA: Applications in Different Diseases.
    Ranucci R
    Methods Mol Biol; 2019; 1909():3-12. PubMed ID: 30580419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When Tissue Is the Issue: Expanding Cell-Free DNA "Liquid Biopsies" to Supernatants and Nonplasma Biofluids.
    Paulson V; Konnick EQ; Lockwood CH
    Clin Lab Med; 2022 Sep; 42(3):485-496. PubMed ID: 36150825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in biomarker discovery using circulating cell-free DNA for early detection of hepatocellular carcinoma.
    Liu M; Zhang Z; Zhang W; Liu SM
    WIREs Mech Dis; 2023; 15(3):e1598. PubMed ID: 36697374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid Biopsy: Is There an Advantage to Analyzing Circulating Exosomal DNA Compared to cfDNA or Are They the Same?
    Kahlert C
    Cancer Res; 2019 May; 79(10):2462-2465. PubMed ID: 31043377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell free DNA: revolution in molecular diagnostics - the journey so far.
    Nandi K; Verma R; Dawar R; Goswami B
    Horm Mol Biol Clin Investig; 2020 Feb; 41(1):. PubMed ID: 32083442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting tumour content of liquid biopsies from cell-free DNA.
    Cardner M; Marass F; Gedvilaite E; Yang JL; Tsui DWY; Beerenwinkel N
    BMC Bioinformatics; 2023 Sep; 24(1):368. PubMed ID: 37777714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements.
    Tuaeva NO; Falzone L; Porozov YB; Nosyrev AE; Trukhan VM; Kovatsi L; Spandidos DA; Drakoulis N; Kalogeraki A; Mamoulakis C; Tzanakakis G; Libra M; Tsatsakis A
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology.
    Ponti G; Manfredini M; Tomasi A
    Crit Rev Oncol Hematol; 2019 Sep; 141():36-42. PubMed ID: 31212145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-Educated Platelet RNA and Circulating Free RNA: Emerging Liquid Biopsy Markers for Different Tumor Types.
    Hu H; Song H; Han B; Zhao H; He J
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):80. PubMed ID: 38420812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Value of Cell-Free Circulating DNA Profiling in Patients with Skin Diseases.
    Ma J; Teng Y; Youming H; Tao X; Fan Y
    Methods Mol Biol; 2023; 2695():247-262. PubMed ID: 37450124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.